These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31741363)

  • 21. [Efficacy of pulsed-dye laser on residual red lesions of cutaneous leishmaniasis].
    Slaoui W; Chiheb S; Benchikhi H
    Ann Dermatol Venereol; 2015 Jan; 142(1):17-20. PubMed ID: 25600790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the long pulsed high fluence alexandrite laser therapy of leg telangiectasia.
    Brunnberg S; Lorenz S; Landthaler M; Hohenleutner U
    Lasers Surg Med; 2002; 31(5):359-62. PubMed ID: 12430154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhodamine intense pulsed light versus conventional intense pulsed light for facial telangiectasias.
    Piccolo D; Crisman G; Kostaki D; Cannarozzo G; Sannino M; Chimenti S
    J Cosmet Laser Ther; 2016; 18(2):80-5. PubMed ID: 26736070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial.
    Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of pulsed dye laser on cutaneous leishmaniasis and its impact on the Dermatology Life Quality Index.
    Elsaie ML; Ibrahim SM
    J Cosmet Laser Ther; 2018 Jun; 20(3):152-155. PubMed ID: 28665162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy.
    Goldman MP; Fitzpatrick RE
    J Dermatol Surg Oncol; 1990 Apr; 16(4):338-44. PubMed ID: 2324370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dual wavelength approach for laser/intense pulsed light source treatment of lower extremity veins.
    Sadick NS
    J Am Acad Dermatol; 2002 Jan; 46(1):66-72. PubMed ID: 11756948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable-pulse Nd:YAG laser in the treatment of facial telangiectasias.
    Bevin AA; Parlette EC; Domankevitz Y; Ross EV
    Dermatol Surg; 2006 Jan; 32(1):7-12. PubMed ID: 16393592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser.
    Clark C; Cameron H; Moseley H; Ferguson J; Ibbotson SH
    Lasers Med Sci; 2004; 19(1):1-5. PubMed ID: 15316851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of pulsed dye laser versus long pulsed Nd:YAG laser treatment in recalcitrant viral warts.
    Shin YS; Cho EB; Park EJ; Kim KH; Kim KJ
    J Dermatolog Treat; 2017 Aug; 28(5):411-416. PubMed ID: 27791434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of spider veins of the leg using a long-pulsed Nd:YAG laser (Versapulse) at 532 nm.
    McMeekin TO
    J Cutan Laser Ther; 1999 Sep; 1(3):179-80. PubMed ID: 11360415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular-specific laser wavelength for the treatment of facial telangiectasias.
    Dudelzak J; Hussain M; Goldberg DJ
    J Drugs Dermatol; 2009 Mar; 8(3):227-9. PubMed ID: 19271368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractional 532-nm KTP diode laser and 595-nm pulsed dye laser in treatment of facial telangiectatic erythema.
    Nam CH; Kim MH; Hong SP; Park BC
    J Cosmet Dermatol; 2019 Jun; 18(3):783-787. PubMed ID: 29974643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment.
    Levy JL; Elbahr C; Jouve E; Mordon S
    Lasers Surg Med; 2004; 34(3):273-6. PubMed ID: 15022257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalized essential telangiectasia treated with PDL.
    Powell E; Markus R; Malone CH
    J Cosmet Dermatol; 2021 Apr; 20(4):1086-1087. PubMed ID: 33405306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pulsed dye laser with a 10-mm beam diameter and a pigmented lesion window for purpura-free photorejuvenation.
    Galeckas KJ; Ross EV; Uebelhoer NS
    Dermatol Surg; 2008 Mar; 34(3):308-13. PubMed ID: 18177402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized settings for Nd:YAG laser treatments of leg telangiectasias.
    Christiansen K; Drosner M; Bjerring P
    J Cosmet Laser Ther; 2015 Apr; 17(2):69-76. PubMed ID: 25415373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the ultra-long pulse width pulsed dye laser and elliptical spot to treat resistant nasal telangiectasia.
    Madan V; Ferguson J
    Lasers Med Sci; 2010 Jan; 25(1):151-4. PubMed ID: 19636662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of spider veins with the 595 nm pulsed-dye laser.
    Bernstein EF; Lee J; Lowery J; Brown DB; Geronemus R; Lask G; Hsia J
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):746-50. PubMed ID: 9810891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.